CRISPR-/Cas9 based genome editing for treating genetic disorders and diseases / 
editor, Luis María Vaschetto, Oncativo, Córdoba, Argentina. 
 - First edition. 
 - London:  CRC Press,  2022. 
 - vi, 262 pages :  illustrations ; 
<br/><br/> "A Science Publishers book." 
<br/><br/>Includes bibliographical references and index. 
<br/><br/> "The field of genome editing has progressed incredibly in the last few years mainly due to the emergence of versatile genome editing tools such as endonuclease-based systems which can be used to efficiently edit gene sequences in a targeted fashion. The CRISPR/Cas9 genome editing system represents an easy-to-use and low-cost alternative for gene editing that has revolutionized research in many different areas ranging from medicine and biotechnology, by democratizing genome editing in laboratories around the world. Remarkably, the CRISPR/Cas9-mediated gene editing system can be used to replace/correct nucleotide mutations associated with genetic disorders and diseases. The objective of this book is to shed light on the CRISPR/Cas9 system and related genome engineering technologies in therapeutics and gene therapy"-- 
<br/><br/><label>ISBN: </label>9780367542863 9780367542870 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CRISPR-Cas Systems<br/>CRISPR-Associated Protein 9<br/>Gene Editing<br/>Genetic Therapy
<br/><br/><label>Dewey Class. No.: </label>572.88078 VAS